Tim Kaine actually said...

"the drug that you guys did not develop and you were not doing any R&D on, the dramatic increases in price were all going to fund other company operations either with respect to return on the investors..."

"In your thinking about this free market system you are describing, is it a factor of relevance at all that the absence of a drug, a dermatological drug, might cause, you know, a minor concern and the ..."

"I think we have been too aggressive--too aggressive on pricing."

"the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine."